LB Pharmaceuticals Inc.
LBRX Nasdaq
SEC CIK 1691082
Follow LB Pharmaceuticals
Weekly email: filings, results, news
Net income
−$51.6M
−959.4% vs same quarter last year
EPS, diluted
−$1.71
+87.4% vs same quarter last year
Operating cash flow
−$37.6M
−571.5% vs same quarter last year
Source: SEC XBRL filings · latest filing
News
No stories filed under LB Pharmaceuticals yet - coverage appears here as the news feed clusters it.